Search research articles
Contact Us
Filters
Showing results (171-180 of 236) with videos related to
Page
of 24
Sort By:
Journal of Translational Medicine
|
September 21, 2011
SITC/iSBTc Cancer Immunotherapy Biomarkers Resource Document: online resources and useful tools - a compass in the land of biomarker discovery
Davide Bedognetti, James M Balwit, Ena Wang, et al.
Science (New York, N.Y.)
|
November 7, 2015
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
Ayelet Sivan, Leticia Corrales, Nathaniel Hubert, et al.
Oncoimmunology
|
January 27, 2017
Human melanomas and ovarian cancers overexpressing mechanical barrier molecule genes lack immune signatures and have increased patient mortality risk
Elise P Salerno, Davide Bedognetti, Ileana S Mauldin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 2019
Extended 5-Year Follow-up Results of a Phase Ib Study (BRIM7) of Vemurafenib and Cobimetinib in <i>BRAF</i>-Mutant Melanoma
Antoni Ribas, Adil Daud, Anna C Pavlick, et al.
Journal for Immunotherapy of Cancer
|
March 22, 2019
Phase 1/2 study of epacadostat in combination with ipilimumab in patients with unresectable or metastatic melanoma
Geoffrey T Gibney, Omid Hamid, Jose Lutzky, et al.
Journal for Immunotherapy of Cancer
|
June 22, 2022
Antibody and T cell responses to COVID-19 vaccination in patients receiving anticancer therapies
Sherin Juliet Rouhani, Jovian Yu, Daniel Olson, et al.
Immunity
|
December 18, 2014
STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors
Seng-Ryong Woo, Mercedes B Fuertes, Leticia Corrales, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
December 21, 2005
Phase 2 study of the g209-2M melanoma peptide vaccine and low-dose interleukin-2 in advanced melanoma: Cancer and Leukemia Group B 509901
John D Roberts, Donna Niedzwiecki, William E Carson, et al.
Cancer Immunology Research
|
June 13, 2025
Tumor cell-intrinsic Decr2 regulates ferroptosis and immunotherapy efficacy
Shuyin Li, Jason W Shapiro, Hardik Shah, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 17, 2009
A designer ligand specific for Kv1.3 channels from a scorpion neurotoxin-based library
Zoltan Takacs, Megan Toups, Astrid Kollewe, et al.
Page
of 24
Search research articles
Search
Showing results (171-180 of 236) with videos related to
Sort By:
Page
of 24
Journal of Translational Medicine
|
September 21, 2011
SITC/iSBTc Cancer Immunotherapy Biomarkers Resource Document: online resources and useful tools - a compass in the land of biomarker discovery
Davide Bedognetti, James M Balwit, Ena Wang, et al.
Science (New York, N.Y.)
|
November 7, 2015
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
Ayelet Sivan, Leticia Corrales, Nathaniel Hubert, et al.
Oncoimmunology
|
January 27, 2017
Human melanomas and ovarian cancers overexpressing mechanical barrier molecule genes lack immune signatures and have increased patient mortality risk
Elise P Salerno, Davide Bedognetti, Ileana S Mauldin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 2019
Extended 5-Year Follow-up Results of a Phase Ib Study (BRIM7) of Vemurafenib and Cobimetinib in <i>BRAF</i>-Mutant Melanoma
Antoni Ribas, Adil Daud, Anna C Pavlick, et al.
Journal for Immunotherapy of Cancer
|
March 22, 2019
Phase 1/2 study of epacadostat in combination with ipilimumab in patients with unresectable or metastatic melanoma
Geoffrey T Gibney, Omid Hamid, Jose Lutzky, et al.
Journal for Immunotherapy of Cancer
|
June 22, 2022
Antibody and T cell responses to COVID-19 vaccination in patients receiving anticancer therapies
Sherin Juliet Rouhani, Jovian Yu, Daniel Olson, et al.
Immunity
|
December 18, 2014
STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors
Seng-Ryong Woo, Mercedes B Fuertes, Leticia Corrales, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
December 21, 2005
Phase 2 study of the g209-2M melanoma peptide vaccine and low-dose interleukin-2 in advanced melanoma: Cancer and Leukemia Group B 509901
John D Roberts, Donna Niedzwiecki, William E Carson, et al.
Cancer Immunology Research
|
June 13, 2025
Tumor cell-intrinsic Decr2 regulates ferroptosis and immunotherapy efficacy
Shuyin Li, Jason W Shapiro, Hardik Shah, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 17, 2009
A designer ligand specific for Kv1.3 channels from a scorpion neurotoxin-based library
Zoltan Takacs, Megan Toups, Astrid Kollewe, et al.
Page
of 24